Brigida Anna Maiorano

Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma

Ernesto Rossi, Brigida Anna Maiorano, Monica Maria Pagliara et al. · Frontiers in Oncology · 2019 · 46 citations · Full text

Metastatic Conjunctival Melanoma, Ocular Disease, Ophthalmology +10

Efficacy of immune checkpoint inhibitors in different types of melanoma

Ernesto Rossi, Giovanni Schinzari, Brigida Anna Maiorano et al. · Human Vaccines & Immunotherapeutics · 2020 · 37 citations · Full text

Checkpoint Inhibitors, Conjunctival Melanoma, Medicine +11

Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future Perspectives.

Brigida Anna Maiorano, Mauro Francesco Pio Maiorano, Domenica Lorusso et al. · Preprints.org · 2021 · 23 citations · Full text

Future Perspectives, Medicine, Immune Checkpoint Inhibitors +15

Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a)

Marco Stellato, Sebastiano Buti, Marco Maruzzo et al. · International Journal of Molecular Sciences · 2023 · 16 citations · Full text

Renal Pathology, Papillary Histology, Pathology +20

First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer

Chiara Mercinelli, Marco Moschini, Antonio Cigliola et al. · Journal of Clinical Oncology · 2024 · 13 citations